Arginine Supplementation in MELAS Syndrome: What Do We Know about the Mechanisms?
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25073629 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Camila D S Barros und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04039-032,…. Hauptthemen laut MEDLINE: MELAS Syndrome, Acidosis, Lactic, Stroke. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundação de Amparo a Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
MELAS syndrome, characterized by mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes, represents a devastating mitochondrial disease, with the stroke-like episodes being its primary manifestation. Arginine supplementation has been used and recommended as a treatment for these acute attacks; however, insufficient evidence exists to support this treatment for MELAS. The mechanisms underlying the effect of arginine on MELAS pathophysiology remain unclear, although it is hypothesized that arginine could increase nitric oxide availability and, consequently, enhance blood supply to the brain. A more comprehensive understanding of these mechanisms is necessary to improve treatment strategies, such as dose and regimen adjustments; identify which patients could benefit the most; and establish potential markers for follow-up. This review aims to analyze the existing evidence concerning the mechanisms through which arginine supplementation impacts MELAS pathophysiology and provide the current scenario and perspectives for future investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurology, Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil.
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Fundação de Amparo a Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)
Zitieren
APA
Barros, C. D. S., Coutinho, A., & Tengan, C. H. (2024). Arginine Supplementation in MELAS Syndrome: What Do We Know about the Mechanisms?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073629
Vancouver
Barros CDS, Coutinho A, Tengan CH. Arginine Supplementation in MELAS Syndrome: What Do We Know about the Mechanisms?. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25073629
BibTeX
@article{Barros2024,
author = {Barros, Camila D S and Coutinho, Aryane and Tengan, Celia H},
title = {Arginine Supplementation in MELAS Syndrome: What Do We Know about the Mechanisms?},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25073629}
}
EUVIMED